Comparison between a guaiac and three immunochemical faecal occult blood tests in screening for colorectal cancer

European Journal of Cancer

Volumn 48, Issue 16, 2012, Pages 2969-2976

  Faivre, J ^a   Dancourt, V ^b   Denis, B ^c   Dorval, E ^d   Piette, C ^e   Perrin, Ph ^c   Bidan, J M ^f   Jard, C ^g   Jung, S ^h   Levillain, R ⁱ   Viguier, J ^d   Bretagne, J F ^j  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b Chu   (France)

^c ADECA Alsace   (France)

^d UNIVERSITY HOSPITAL OF TOURS   (France)

^e ADECI 35 ^*  (France)

^f Laboratoire du CES de la CPAM de Dijon   (France)

^g Laboratoire du CES de la CPAM de Rennes   (France)

^h Laboratoire du CES de la CPAM de Mulhouse   (France)

ⁱ IRSA Tours   (France)

^j RENNES UNIVERSITY HOSPITAL   (France)

more..

Author keywords

Colorectal cancer; Faecal occult blood tests; Screening

Indexed keywords

GUAIAC;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CARCINOMA IN SITU; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; EQUIPMENT; FEMALE; GUAIAC BASED FECAL OCCULT BLOOD TEST; HUMAN; IMMUNOCHEMICAL FECAL OCCULT BLOOD TEST; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADENOMA; AGED; CARCINOMA; COLONOSCOPY; COLORECTAL NEOPLASMS; FECES; FEMALE; FRANCE; GUAIAC; HEMOGLOBINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL;

EID: 84867578944     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.04.007     Document Type: Article

References (31)

1. A. Belot, P. Grosclaude, and N. Bossard Cancer incidence and mortality in France over the period 1980-2005 Rev Epidemiol Sante Publique 56 2008 159 175
2. F. Berrino, R. De Angelis, and M. Sant Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study Lancet Oncol 8 2007 773 783
3. N. Bossard, M. Velten, and L. Remontet Survival of cancer patients in France: a population-based study from the Association of the French Cancer Registries (FRANCIM) Eur J Cancer 43 2007 149 160
4. E. Monnet, J. Faivre, L. Raymond, and I. Garau Comparability of colorectal cancer survival data in three European population-based registries Eur J Cancer Prev 7 1998 127 134
5. S.J. Winawer, and A.G. Zauber The advanced adenoma as the primary target of screening Gastrointest Endosc Clin N Am 12 2002 1 9
6. O. Kronborg, C. Fenger, J. Olsen, O.D. Jorgensen, and O. Sondergaard Randomized study as screening for colorectal cancer with faecal-occult-blood test Lancet 348 1996 1467 1471
7. J.D. Hardcastle, J.O. Chamberlain, and M.H. Robinson Randomized controlled trial of fecal-occult-blood screening for colorectal cancer Lancet 348 1996 1472 1477
8. J. Faivre, V. Dancourt, and C. Lejeune Reduction in colorectal cancer mortality by fecal occult blood screening in a controlled study in France Gastroenterology 126 2004 1674 1680
9. Council of the European Union. Council recommendation of 2 December 2003 on cancer screening. Official Journal of the European Union. 2003/878/EC, L327/34-38.
10. H. Goulard, M. Boussac-Zarebska, R. Ancelle-Park, and J. Bloch French colorectal cancer screening pilot programme: results of the first round J Med Screen 15 2008 143 148
11. D.J. Holden, D.E. Jonas, D.S. Porterfield, D. Reuland, and R. Harrio Systematic review: enhancing the use and quality of colorectal cancer screening Ann Intern Med 152 2010 668 676
12. L.H. Sobin, and Ch. Wittekind TNM classification of malignant tumours 7th ed. 2009 Wiley New York
13. A. Schatzkin, R.J. Connor, P.R. Taylor, and B. Bunnag Comparing new and old screening tests when a reference procedure cannot be performed on all screenees. Example of automated cytometry for early detection of cervical cancer Am J Epidemiol 125 1987 672 678
14. H. Cheng, and M. Macaluso Comparison of the accuracy of two tests with a confirmatory procedure limited to positive results Epidemiology 8 1997 104 106
15. L.G. van Rossum, A.F. van Rijn, and R.J. Laheij Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population Gastroenterology 135 2008 82 90
16. L. Hol, M.E. van Leerdam, and M. van Ballegooijen Screening for colorectal cancer: randomized trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoïdoscopy Gut 59 2010 62 68
17. G. Castiglione, G. Grazzini, and G. Miccinesi Basic variables at different positivity threshold of a quantitative immunochemical test for faecal occult blood J Med Screen 9 2002 99 103
18. L. Guittet, V. Bouvier, and N. Mariotte Performance of immunochemical faecal occult blood test in colorectal cancer screening in average-risk population according to positivity threshold and number of samples Int J Cancer 125 2009 1127 1133
19. G. Grazzini, C.B. Visioli, and M. Zorri Immunochemical faecal occult blood test: number of samples and positivity cut-off. What is the best strategy for colorectal cancer screening? Br J Cancer 100 2009 259 265
20. L. Guittet, V. Bouvier, and N. Mariotte Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population Gut 56 2007 210 214
21. V. Dancourt, C. Lejeune, C. Lepage, M.C. Gailliard, B. Meny, and J. Faivre Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms Eur J Cancer 44 2008 2254 2258
22. N. Segnan, C. Senore, and B. Andreoni SCORE3 Working Group-Italy. Comparing attendance and detection rate of colonoscopy with sigmoïdoscopy and FIT for colorectal cancer screening Gastroenterology 132 2007 2304 2312
23. D.I. Park, S. Ryu, and Y.H. Kim Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening Am J Gastroenterol 105 2010 2017 2025
24. L.G. Van Rossum, A.F. Van Rijn, and M.G.H. Van Oijen False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening test Int J Cancer 125 2009 746 750
25. A. Vilkin, P. Rozen, and Z. Levi Performance characteristics and evaluation of an automated-developed and quantitative immunochemical fecal occult blood screening test Am J Gastroenterol 100 2005 2519 2525
26. G. Grazzini, L. Ventura, and M. Zappa Influence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from the Florence district Gut 59 2010 1511 1515
27. H. Nakama, B. Zhang, and X. Zhang The evaluation of the optimum cut-off point in immunochemical occult blood testing in screening for colorectal cancer Eur J Cancer 37 2001 398 401
28. P. Rozen, D. Comaneshter, and Z. Levi Cumulative evaluation of a quantitative immunochemical fecal occult blood test to determine its optimal clinical use Cancer 116 2010 2115 2125
29. S.J. Stryker, B.G. Wolff, C.E. Culp, S.D. Libbe, D.M. Ilstrup, and R.L. MacCarty Natural history of untreated colonic polyps Gastroenterology 93 1987 1009 1013
30. R.J. Schlemper, R.H. Riddell, and Y. Kato The Vienna classification of gastro intestinal epithelial neoplasia Gut 47 2000 251 255
31. B. Denis, C. Peters, and C. Chapelain Diagnostic accuracy of community pathologists in the interpretation of colorectal polyps Eur J Gastroenterol Hepatol 21 2009 1153 1160